STERLINBIO

For and on behalf of Promoter and Promoter Group has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

JM Financial Asset Reconstruction Company Private Limited has submitted to the Exchange vide letter dated March 25, 2014 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

JM Financial Services Limited has submitted to the Exchange vide letter dated July 22, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Chetan J. Sandesara has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Chetan J. Sandesara for and on behalf of Promoter and Promoter Group has submitted to the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers), 2011 and amendments thereof.

Chetan J. Sandesara for and on behalf of Promoter and Promoter Group has submitted to the Exchange a copy of Regulation 31(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers), 2011 and amendments thereof.

Jangpriya Investments Pvt. Ltd. has submitted to the Exchange a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sterling Biotech Limited has submitted to the Exchange a copy of the Disclosure under Regulation 8A(4) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers), 1997.

Sterling Biotech Limited has submitted to the Exchange a copy of the Disclosure under Regulation 8A(4) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers), 1997.

Sterling Biotech Limited Sterling Biotech Limited has submitted to the Exchange a copy of disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Puja Aqua Farms Private Limited has submitted to the Exchange a copy of Disclosure under Regulation 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Paysan Publishers Private Limited has submitted to the Exchange a copy of Disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and Regulation 13(4A) of Seurities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 and amendments thereof.

Sterling Biotech Limited has submitted to the Exchange a copy of disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and Regulation 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

Sterling Biotech Limited has submitted to the Exchange a copy of the Disclosure under Regulation 8A(4) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers), 1997.

Sterling Biotech Limited has submitted the Exchange a copy of disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 1997.

Sterling Biotech Limited has submitted the Exchange a copy of disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 1997.

Sterling Biotech Limited has submitted the Exchange a copy of disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 1997.

Sterling Biotech Limited has submitted the Exchange a copy of disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 1997.

Sterling Biotech Limited has submitted the Exchange a copy of disclosure under Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 1997.

Sterling Biotech Limited has submitted to the Exchange a copy of Disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.

Sterling Biotech Limited has submitted to the Exchange a copy of Disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997.

Sterling Biotech Limited has submitted to the Exchange a disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997

Sterling Biotech Limited has informed the Exchange that ABN AMRO Bank NV London Branch has sold 5,00,000 shares through NSE and 5,00,000 shares through NSE aggregating to 0.46% the share capital of Sterling Biotech Limited on April 10, 2006. The mode of sale is Secondary Market and the shareholding of ABN AMRO Bank NV after the said sale is 12,271,695 shares aggregating to 5.55% of the share capital of Sterling Biotech Limited.

Citibank N.A. has informed the Exchange that ABN AMRO Bank NV London Branch has acquired 9,387,970 shares aggregating to 4.90% of the total paid up capital of Sterling Biotech Limited on September 09, 2005. The mode of acquisition is Convertible Bonds getting converted into Equity shares and the shareholding of ABN AMRO Bank NV London Branch after the said acquisition is 17,054,508 shares aggregating to 8.90% of the total paid up capital of Sterling Biotech Limited.